Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Interest Coverage Ratio: 2016-2025

Historic Interest Coverage Ratio for Theravance Biopharma (TBPH) over the last 9 years, with Sep 2025 value amounting to -11.27.

  • Theravance Biopharma's Interest Coverage Ratio rose 34.51% to -11.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -13.01, marking a year-over-year increase of 25.29%. This contributed to the annual value of -18.44 for FY2024, which is 22.66% up from last year.
  • Theravance Biopharma's Interest Coverage Ratio amounted to -11.27 in Q3 2025, which was down 174.09% from -4.11 recorded in Q2 2025.
  • In the past 5 years, Theravance Biopharma's Interest Coverage Ratio registered a high of -4.11 during Q2 2025, and its lowest value of -45.29 during Q1 2023.
  • For the 3-year period, Theravance Biopharma's Interest Coverage Ratio averaged around -19.06, with its median value being -17.20 (2024).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first slumped by 936.98% in 2021, then surged by 83.15% in 2025.
  • Theravance Biopharma's Interest Coverage Ratio (Quarterly) stood at -26.28 in 2021, then declined by 20.59% to -31.69 in 2022, then spiked by 68.40% to -10.02 in 2023, then crashed by 42.85% to -14.31 in 2024, then skyrocketed by 34.51% to -11.27 in 2025.
  • Its Interest Coverage Ratio was -11.27 in Q3 2025, compared to -4.11 in Q2 2025 and -22.45 in Q1 2025.